Hualan Biological Bacterin Inc. is engaged in the R&D, production and sales of vial vaccines, bacterial vaccines and etc.

Navigation
  • Hualan Biological Vaccine Inc.

    Wechat attention
    consulting service

  • Hualan Biological Vaccine Inc.

    Wechat attention
    consulting service

contact us

0373-3559991

fax:0373-3519991

Adverse reaction Telephone:0373-3552342

address:Jia No. 1-1, Hualan Avenue, Xinxiang City, Henan Province

1

Products

Hualan is the birthplace of the first marketed Influenza A (H1N1) Vaccine, (Split Virion) in the globe, and the first company whose plasma products gained GMP certificate in China

  • [ Group A and C Meningococcal Polysaccharide Vaccine ]

    0.5mL/dose

     ...

  • [ Influenza Vaccine (Split Virion), Inactivated, Quadrivalent ]

    0.5mL//vial

    Please read this ins...

  • [ Influenza Vaccine (Split Virion), Inactivated, Quadrivalent ]

    0.5mL//syringe

    Please read this ins...

  • [ Group ACYW135 Meningococcal Polysaccharide Vaccine ]

    200µg/vial

    [Drug Name]Generic N...

  • [ Recombinant Hepatitis B Vaccine (Hansenula Polymorpha) ]

    10µg /0.5mL/syringe

    [Drug Name]Generic N...

  • [ Recombinant Hepatitis B Vaccine (Hansenula Polymorpha) ]

    10µg /0.5mL/vial

    [Drug Name]Generic N...

  • [ Influenza Vaccine (Split Virion), Inactivated ]

    0.25mL/syringe

    [Drug Name]Generic N...

  • [ Influenza Vaccine (Split Virion), Inactivated ]

    0.5mL/syringe

    [Drug Name]Generic N...

  • [ Influenza Vaccine (Split Virion), Inactivated ]

    0.5mL/vial

    [Drug Name]Generic N...

learn more

ABOUT US

Hualan Biological Vaccine Inc.
Mainstay of Influenza Prevention and Control in China

Hualan Biological Vaccine Inc., a holding subsidiary of the Hualan Biological Engineering Inc., is engaged in the R&D, production and sale of vaccines. In 2009, it only took 87 days to develop the world’s first H1N1 Vaccine, and undertook nearly 40 % of the national storage task. It is the first influenza vaccine manufacturer in China, and the fifth in the world that passes the Pre-Qualification of World Health Organization. H7N9 and Quadrivalent Influenza Vaccine developed and applied by Hualan firstly in China are listed as key development projects by Ministry of Science and Technology. At present, there are six kinds of vaccines on the market, including Influenza Vaccine (Split Virion), Inactivated (Adult), Group ACYW135 Meningococcal Polysaccharide Vaccine, Recombinant Hepatitis B Vaccine, Influenza Vaccine (Split Virion), Inactivated (Children), Influenza Vaccine (Split, Virion), Inactivated, Quadrivalent (Adult), Group A and Group C Meningococcal Polysaccharide Vaccine.

learn more

NEWS

  • 2023-12-28

    Hualan Bio rushed to the disaster area in Gansu Province

    At 23: 59 on December 18th, an earthquak...

    learn more
  • 2023-05-31

    Rabies treatment: human rabies immunoglobulin + rabies vaccine

    Rabies treatment: human rabies immu...

    learn more
  • 2023-04-23

    Hualan Vac at China Biological Products Annual Conference

    Hualan Vac at China Biological Prod...

    learn more
  • 2023-04-10

    Congratulation! Hualan’s Tetanus Vaccine is Now Available!

    Congratulation! Hualan’s Tetanus Vaccine...

    learn more
  • 2023-04-10

    Congratulation! Hualan’s Rabies Vaccine Is Now Available!

    Congratulation! Hualan’s Rabies Vaccine ...

    learn more
  • 2021-10-20

    省领导莅临郑洛新国家自主创新示范区华兰生物进行调研

      2月9日上午,省委书记、省人大常委会主任谢伏瞻,省委副书记、省长陈润儿带领省...

    learn more
  • 2021-10-20

    全球疫苗市场现状分析以及2011市场战略趋势

      【慧聪制药工业网】成本控制、流感疫苗之间竞争的日益加剧、后期研发线新产品的缺...

    learn more
  • 2021-10-20

    全球***能够用于3岁以上人群接种的甲型H1N1流感疫苗获批获得国家400万的订单

      9月4日,国家食品药品监管局批准了华兰生物疫苗有限公司甲型H1N1流感疫苗注...

    learn more
  • 2021-10-20

    华兰生物向部分发展中国家捐赠流感疫苗

      2018年9月9日,在2018年世界流感大会于北京召开之际,华兰生物在中国疾...

    learn more
  • 2021-10-20

    Hualan Bio's Influenza Vaccine Passed GMP Qualification of Ukraine

      March 15, 2017, Hualan Bio's influ...

    learn more
Copyright Hualan Biological Vaccine Inc. ICP: